[1]
“Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures”, Braz. J. Pharm. Sci., vol. 55, p. e17351, Nov. 2019, doi: 10.1590/s2175-97902019000117351.